
AODT-0015
Tesamorelin
FDA-approved GHRH analogue for HIV-associated lipodystrophy. Reduces visceral fat and improves body composition.
- CAS
- 218949-48-5
- Purity
- ≥99.21%
- Grade
- GMP
Priority Sales Hotline
Tap to chat with us

AODT-0015
FDA-approved GHRH analogue for HIV-associated lipodystrophy. Reduces visceral fat and improves body composition.
We use cookies
We use essential cookies to make our site work, and optional analytics & preference cookies to improve your experience. See our Cookie Policy.